# Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow

> **NCT02779582** · PHASE3 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 59 (actual)

## Conditions studied

- Perimenopause
- Menstrual Cramps

## Interventions

- **DRUG:** Oral Micronized Progesterone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02779582
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2018-06-01
- **Final completion:** 2018-06-01
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02779582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02779582, "Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02779582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*